FISCAL NOTE
Date Requested: February 24, 2015 Time Requested: 09:58 AM |
Agency: |
Supreme Court of Appeals |
CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
3308 |
Introduced |
HB2880 |
|
CBD Subject: |
Crime |
---|
|
FUND(S):
Sources of Revenue:
General Fund
Legislation creates:
A New Program
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
Currently, this bill would require the Court to participate in a pilot program in five Adult Drug Court (ADC) programs, wherein persons who have been clinically diagnosed with opioid addiction are selected by the ADC program to receive medically assisted treatment.
Fiscal Note Detail
Effect of Proposal |
Fiscal Year |
2015 Increase/Decrease (use"-") |
2016 Increase/Decrease (use"-") |
Fiscal Year (Upon Full Implementation) |
1. Estmated Total Cost |
0 |
2,880,000 |
2,880,000 |
Personal Services |
0 |
0 |
0 |
Current Expenses |
0 |
0 |
0 |
Repairs and Alterations |
0 |
0 |
0 |
Assets |
0 |
0 |
0 |
Other |
0 |
0 |
0 |
2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
This bill has serious fiscal impact on the judiciary’s budget. Specifically, the Court has never paid for vivitrol. Programs currently using it are doing so through either Medicaid or a federal grant. Medicaid will only pay for up to one year. This could raise an issue, as the average time for successful completion of ADC is 18 months.
Please note that vivitrol costs $800.00 to $1,200.00 per shot, and shots are administered monthly. As this program authorizes up to 200 participants from ADC programs, the upper range of cost (if there is no Medicaid or insurance coverage for the vivitrol), would be $2,880,000.00 per year, or $14,400.00, annually, per participant.
Memorandum
Person submitting Fiscal Note: Tina A. Payne
Email Address: tina.payne@courtswv.gov